Our data also reveal the presence of high levels of pY160, the monomeric signalling active form of Grb2, in cancer tissue cells and suggest that this could be a marker for proliferative MAPK activation and resulting oncogenic outcome. The gene discussed is IRS4; the disease is cancer.